@Article{信息:doi 10.2196 / / jmir。7028，作者="V{\"a}lim{\"a}ki, Maritta和Kannisto, Kati Anneli和Vahlberg, Tero和H{\"a}t{\"o}nen, Heli和Adams, Clive E"，标题="短短信鼓励坚持药物治疗和跟踪精神病患者(Mobile.Net):芬兰随机控制试验"，期刊="J Med Internet Res"，年="2017"，月="7月"，日="12"，卷="19"，数="7"，页="e245"，关键词="短信;精神疾病;随机对照试验;背景:短信服务(短消息服务[SMS])有可能针对大量患有长期疾病(如严重精神障碍)的人群，这些人可能难以坚持治疗。关于移动技术干预对这些患者影响的可靠研究仍然很少。目的:我们研究的主要目的是调查个性化短信对精神病院再入院率、卫生保健服务使用和临床结果的影响。此外，我们还分析了治疗费用。方法:2011年9月至2012年11月，我们随机将1139人分配到定制短信干预组(n=569)或常规护理组(n=570)。参与者在长达12个月或常规护理期间都会收到半自动短信。 The primary outcome, based on routinely collected health register data, was patient readmission into a psychiatric hospital during a 12-month follow-up period. Secondary outcomes were related to other service use, coercion, medication, adverse events, satisfaction, social functioning, quality of life, and economic factors (cost analysis). Results: There was 98.24{\%} (1119/1139) follow-up at 12 months. Tailored mobile telephone text messages did not reduce the rate of hospital admissions (242/563, 43.0{\%} of the SMS group vs 216/556, 38.8{\%} of the control group; relative risk 1.11; 95{\%} CI 0.92-1.33; P=.28), time between hospitalizations (mean difference 7.0 days 95{\%} CI --8.0 to 24.0; P=.37), time spent in a psychiatric hospital during the year (mean difference 2.0 days 95{\%} CI --2.0 to 7.0; P=.35), or other service outcomes. People who received text messages were less disabled, based on Global Assessment Scale scores at the time of their readmission, than those who did not receive text messages (odds ratio 0.68; 95{\%} CI 0.47-0.97; P=.04). The costs of treatment were higher for people in the SMS group than in the control group (mean {\texteuro}10,103 vs {\texteuro}9210, respectively, P<.001). Conclusions: High-grade routinely collected data can provide clear outcomes for pragmatic randomized trials. SMS messaging tailored with the input of each individual patient did not decrease the rate of psychiatric hospital visits after the 12 months of follow-up. Although there may have been other, more subtle effects, the results of these were not evident in outcomes of agreed importance to clinicians, policymakers, and patients and their families. Trial Registration: International Standard Randomized Controlled Trial Number (ISRCTN): 27704027; http://www.isrctn.com/ISRCTN27704027 (Archived by WebCite at http://www.webcitation.org/6rVzZrbuz). ", issn="1438-8871", doi="10.2196/jmir.7028", url="//www.mybigtv.com/2017/7/e245/", url="https://doi.org/10.2196/jmir.7028", url="http://www.ncbi.nlm.nih.gov/pubmed/28701292" }